Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0235394 (
wasting
)
8,040
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Despite being a fairly recent discovery,
DOK7
congenital myasthenic syndrome (CMS) is the third most common form of CMS in the United Kingdom.
DOK7
is a postsynaptic protein associated with the AChR clustering pathway. In contrast to AChR deficiency due to epsilon subunit mutations, onset of
DOK7
CMS tends to be later--ages two to three years--and in
DOK7
CMS eye movements are usually spared and anticholinesterases can exacerbate the weakness. The typical phenotype of
DOK7
CMS is of a limb girdle weakness with associated nonspecific myopathic features. The presence of stridor in early onset cases and the observation of tongue
wasting
may be specific clues. Worsening in adulthood is common, particularly affecting bulbar and respiratory function. Treatment with ephedrine or oral salbutamol can result in a slow, steady, and often dramatic improvement over months.
...
PMID:DOK7 congenital myasthenic syndrome. 2327 77